For: | Kurdi M, Moshref RH, Katib Y, Faizo E, Najjar AA, Bahakeem B, Bamaga AK. Simple approach for the histomolecular diagnosis of central nervous system gliomas based on 2021 World Health Organization Classification . World J Clin Oncol 2022; 13(7): 567-576 [PMID: 36157161 DOI: 10.5306/wjco.v13.i7.567] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i7/567.htm |
Number | Citing Articles |
1 |
Maher Kurdi, Ahmed Bamaga, Alaa Alkhotani, Thamer Alsharif, Ghada A Abdel-Hamid, Mohamed E Selim, Taghreed Alsinani, Ahmed Albeshri, Adnan Badahdah, Mazen Basheikh, Saleh Baeesa. Mitochondrial DNA Alterations in Glioblastoma and Current Therapeutic Targets. Frontiers in Bioscience-Landmark 2024; 29(10) doi: 10.31083/j.fbl2910367
|
2 |
Maher Kurdi, Nasser Mulla, Yousef Katib, Taghreed Alsinani, Sahar Hakamy, Bassam MJ Addas, Husam Malibary, Taher F Halawa, Marwa S Farhan, Eyad Faizo, Saleh Baeesa. The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. Biologics: Targets and Therapy 2023; : 15 doi: 10.2147/BTT.S394556
|
3 |
MAHER KURDI, ALAA ALKHOTANI, ABDULRAHMAN SABBAGH, EYAD FAIZO, AHMED I. LARY, AHMED K. BAMAGA, MAJID ALMANSOURI, BADR HAFIZ, THAMER ALSHARIF, SALEH BAEESA. The interplay mechanism between IDH mutation, MGMT-promoter methylation, and PRMT5 activity in the progression of grade 4 astrocytoma: unraveling the complex triad theory. Oncology Research 2024; 32(6): 1037 doi: 10.32604/or.2024.051112
|
4 |
Brandon Lucke-Wold, Burhanuddin Sohail Rangwala, Muhammad Ashir Shafique, Mohammad Arham Siddiq, Muhammad Saqlain Mustafa, Fnu Danish, Rana Muhammad Umer Nasrullah, Noor Zainab, Abdul Haseeb. Focus on current and emerging treatment options for glioma: A comprehensive review. World Journal of Clinical Oncology 2024; 15(4): 482-495 doi: 10.5306/wjco.v15.i4.482
|
5 |
Maher Kurdi, Motaz M. Fadul, Bassam Addas, Eyad Faizo, Ahmed K. Bamaga, Taghreed Alsinani, Yousef Katib, Alaa Alkhotani, Amany A. Fathaddin, Alaa N. Turkistani, Ahmed A. Najjar, Saleh Baeesa, Fadi A. Toonsi, Majid Almansouri, Shadi Alkhayyat. Glioblastoma with PRMT5 gene upregulation is a key target for tumor cell regression. Oncologie 2024; 26(2): 239 doi: 10.1515/oncologie-2023-0534
|
6 |
Taher Halawa, Saleh Baeesa, Motaz M Fadul, Adnan A Badahdah, Maryam Enani, Amany A Fathaddin , Dania Kawass, Alaa Alkhotani, Basem Bahakeem, Maher Kurdi. The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma. Cureus 2023; doi: 10.7759/cureus.41221
|
7 |
Niem Van Thanh Vo, Diem Dinh-Kieu Truong, Phan Thi Xinh, Hoang Anh Vu. Real-time Quantitative Polymerase Chain Reaction Assay for Detecting 1p and 19q Codeletion in Glioma. Biomedical and Biotechnology Research Journal (BBRJ) 2023; 7(4): 563 doi: 10.4103/bbrj.bbrj_196_23
|
8 |
Muhammad Awais, Abdul Rehman, Syed Sarmad Bukhari. Advances in liquid biopsy and virtual biopsy for care of patients with glioma: a narrative review. Expert Review of Anticancer Therapy 2025; : 1 doi: 10.1080/14737140.2025.2489629
|
9 |
Maher Kurdi, Motaz M. Fadul, Bassam J. Addas, Eyad Faizo, Shadi Alkhayyat, Fahad Okal, Alaa Alkhotani, Abdulrahman J. Sabbagh, Mohammed Abutalib, Ahmed K. Bamaga, Amany A. Fathaddin, Saleh Baeesa. The association between NRF2 transcriptional gene dysregulation and IDH mutation in Grade 4 astrocytoma. Oncologie 2023; 25(6): 661 doi: 10.1515/oncologie-2023-0262
|
10 |
M. Kurdi, A. Alkhotani, T. Alsinani, S. Alkhayyat, Y. Katib, Z. Jastaniah, A.J. Sabbagh, N.S. Butt, F.A. Toonsi, M. Alharbi, S. Baeesa. Effects of Radiotherapy Alone Versus Concomitant Radiotherapy With Temozolomide Chemotherapy on the Outcome of IDH-wildtype Glioblastoma Patients. Clinical Oncology 2025; 38: 103741 doi: 10.1016/j.clon.2024.103741
|
11 |
Neha Saini, Amit Kumar Tiwari, Robert Leahy, Nanasaheb Thorat, Atul Kulkarni. Transforming brain cancer biomarker research with patinformatics and SWOT analysis. Drug Discovery Today 2025; 30(3): 104314 doi: 10.1016/j.drudis.2025.104314
|